Obermatt
See Similar Stocks →

Neogen

NSQ:NEOG · US6404911066
Health Care Equipment & SuppliesMedium

360

13
Profit price72
Owner Earnings Yield1
Dividend Yield1
Price/Sales49
EV / Gross Profit24
Price/Book76
Return on Capital19
Cash Return on Capital8
Return on Equity12
EBIT Margin14
Gross Profitability16
Accruals93
Owner Earnings Margin6
Sales growth8
Profit Growth61
Long-Term EPS Growth56
Reinvestment24
Price momentum96
Debt load63
Refinancing67
Debt Payback1
Liquidity39
Analyst ratings18
Opinion Changes50
Price Target Upside67
Market mood1
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Neogen doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded1981
Employees1,611
Websiteneogen.com
ISINUS6404911066
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Animal FeedLivestockVaccinesGeneticsRespiratoryHealth DiagnosticsPet Food and SuppliesEnvironment, Health and Safety (EH&S)BiotechnologyFood and BeverageFood ProcessingLife ScienceManufacturing

Description

Neogen Corporation (Neogen) develops, manufactures and markets a diverse line of products and services dedicated to food and animal safety. The company’s Food Safety segment consists primarily of diagnostic test kits and complementary products (e.g.…

Analysis

Weak and unloved

Neogen Corporation scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is fragile. The company scores 2/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
12
2023202420252026

All-time high

43

Mar 2026

All-time low

8

Jan 2023

Average rank

18

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
49
43
24
20
Price/Earnings
18
40
37
14
Price/Book
76
59
52
14
Dividend Yield
1
1
1
1
Value (overall)
24
37
17
1

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Neogen with its peers
IRIDEX
NAQ:IRIX
69
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Solventum
NYQ:SOLV
62
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Glaukos
NYQ:GKOS
31
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Medline
NSQ:MDLN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
CVRx
NSQ:CVRX
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Inogen
NSQ:INGN
39
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →